Integrating Regulatory Affairs and Business Development: Its Impact on Creation of Company Value
06.18.09 Gaithersburg, MD
Time: 8:00 am-11:30 am
MdBio, a Division of the Tech Council of Maryland, is hosting a half day seminar to outline the many issues that biopharma companies must consider as its products move through the FDA regulatory process. Mr. Covert will join in a panel discussion covering the practical aspects of business development and management of IP during the regulatory process. The following issues will also be addressed:
- What are the “value-creating” events/milestones during the drug development process?
- From an implementation perspective, what activities should be performed, and when, to achieve these milestones?
- How can a biopharma company best leverage these milestones in its efforts to raise capital to achieve the next clinical milestone?
To register for the event, click here.
RSS
twitter